Cargando…

T lymphocyte-targeted immune checkpoint modulation in glioma

Immunomodulatory therapies targeting inhibitory checkpoint molecules have revolutionized the treatment of solid tumor malignancies. Concerns about whether systemic administration of an immune checkpoint inhibitor could impact primary brain tumors were answered with the observation of definitive resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelly, William James, Giles, Amber Jin, Gilbert, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057419/ https://www.ncbi.nlm.nih.gov/pubmed/32051289 http://dx.doi.org/10.1136/jitc-2019-000379

Ejemplares similares

Correction: T lymphocyte-targeted immune checkpoint modulation in glioma
Publicado: (2020)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
por: Pesce, Silvia, et al.
Publicado: (2020)

Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020)

Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions
por: Bitar, Lynn, et al.
Publicado: (2021)

miR-138 exerts anti-glioma efficacy by targeting immune checkpoints
por: Wei, Jun, et al.
Publicado: (2013)

Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses
por: Ding, Mengmeng, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
por: He, Yayi, et al.
Publicado: (2016)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
por: Ho, Rachel L. Y., et al.
Publicado: (2021)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint
por: Verma, Navin Kumar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis
por: Amin, Shefali, et al.
Publicado: (2023)

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
por: Kim, Eileen S., et al.
Publicado: (2016)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades
por: Li, Jun-Yan, et al.
Publicado: (2021)

Targeting Immune Cell Checkpoints during Sepsis
por: Patil, Naeem K., et al.
Publicado: (2017)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
por: Kleinendorst, Simone C., et al.
Publicado: (2022)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

Immune Checkpoints: Therapeutic Targets for Pituitary Tumors
por: Nie, Ding, et al.
Publicado: (2021)

Immune checkpoint: The novel target for antitumor therapy
por: Jiang, Xianghu, et al.
Publicado: (2019)

Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
por: Chen, Miaoqin, et al.
Publicado: (2020)

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)

Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
por: Kimbara, Shiro, et al.
Publicado: (2016)

Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
por: Giannopoulos, Krzysztof
Publicado: (2019)

Immune Checkpoints as a Target for Colorectal Cancer Treatment
por: Passardi, Alessandro, et al.
Publicado: (2017)

Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
por: Dulal, Dharmindra, et al.
Publicado: (2023)

Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood
por: Shen, Shaoping, et al.
Publicado: (2021)

MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
por: Zhou, Huiling, et al.
Publicado: (2023)

Modulation of immune checkpoint regulators in interferon γ induced urothelial carcinoma and activated T-lymphocyte cells by cytostatics
por: Hänze, Jörg, et al.
Publicado: (2023)

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
por: Dmello, Crismita, et al.
Publicado: (2023)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
por: Dosset, Magalie, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients
por: Allegra, Alessandro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r88kunt7apnguepa9irv1625d0